Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126753261 | 12675326 | 1 | I | 20160816 | 20160822 | 20160822 | PER | US-ELI_LILLY_AND_COMPANY-US201608009013 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126753261 | 12675326 | 1 | PS | HUMULIN R U-500 | INSULIN HUMAN | 1 | Subcutaneous | 65 U, EACH MORNING | 18780 | 65 | IU | INJECTION | QD | ||||||
| 126753261 | 12675326 | 2 | SS | HUMULIN R U-500 | INSULIN HUMAN | 1 | Subcutaneous | 60 U, AT LUNCH | 18780 | 60 | IU | INJECTION | |||||||
| 126753261 | 12675326 | 3 | SS | HUMULIN R U-500 | INSULIN HUMAN | 1 | Subcutaneous | 50 U, EACH EVENING | 18780 | 50 | IU | INJECTION | QD | ||||||
| 126753261 | 12675326 | 4 | SS | HUMULIN R U-500 | INSULIN HUMAN | 1 | Subcutaneous | 65 U, EACH MORNING | C509906E | 18780 | 65 | IU | INJECTION | QD | |||||
| 126753261 | 12675326 | 5 | SS | HUMULIN R U-500 | INSULIN HUMAN | 1 | Subcutaneous | 60 U, AT LUNCH | C509906E | 18780 | 60 | IU | INJECTION | ||||||
| 126753261 | 12675326 | 6 | SS | HUMULIN R U-500 | INSULIN HUMAN | 1 | Subcutaneous | 50 U, EACH EVENING | C509906E | 18780 | 50 | IU | INJECTION | QD | |||||
| 126753261 | 12675326 | 7 | SS | HUMULIN R | INSULIN HUMAN | 1 | Subcutaneous | 35 U, UNK | U | 0 | 35 | IU | INJECTION | ||||||
| 126753261 | 12675326 | 8 | C | INVOKANA | CANAGLIFLOZIN | 1 | Unknown | UNK UNK, UNKNOWN | U | 0 | |||||||||
| 126753261 | 12675326 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126753261 | 12675326 | 1 | Diabetes mellitus |
| 126753261 | 12675326 | 7 | Diabetes mellitus |
| 126753261 | 12675326 | 8 | Product used for unknown indication |
| 126753261 | 12675326 | 9 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126753261 | 12675326 | Blood glucose decreased | |
| 126753261 | 12675326 | Blood glucose increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126753261 | 12675326 | 1 | 2016 | 0 | ||
| 126753261 | 12675326 | 2 | 2016 | 0 | ||
| 126753261 | 12675326 | 3 | 2016 | 0 | ||
| 126753261 | 12675326 | 7 | 2015 | 0 |